Abbott Laboratories

ABT: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
Mb?LOCK|>zgzLOCK|$KK?jl

Abbott Earnings: Pockets of Strength More Than Offset Areas of Softness

Abbott's third-quarter results included reported revenue growth of 7%, with US nutrition sales falling 7% and global device revenue up 15% year over year.

Sponsor Center